Evidence map›Paper›PMID 33162881›Full record

ArticleFrontiers in neuroscience2020

Neuroprotective Effect of Optogenetics Varies With Distance From Channelrhodopsin-2 Expression in an Amyloid-β-Injected Mouse Model of Alzheimer's Disease.

Xiaorui Cui, Feng Zhang, Hui Zhang, Xi Huang, Kewei Wang, Ting Huang, Xifei Yang, Liangyu Zou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Optogenetics in Alzheimer's Disease: Focus on Astrocytes.Antioxidants (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Xiaorui CuiDepartment of Neurology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
Feng ZhangIntensive Care Unit, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Hui ZhangDepartment of Neurology, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology), Second Clinical College, Jinan University, Shenzhen, China.
Xi HuangDepartment of Neurology, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology), Second Clinical College, Jinan University, Shenzhen, China.
Kewei WangDepartment of Neurology, Longgang District People's Hospital of Shenzhen, Shenzhen, China.
Ting HuangDepartment of Cerebrovascular Disease, People's Hospital of Yuxi, The Sixth Affiliated Hospital of Kunming Medical University, Yuxi, China.
Xifei YangKey Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
Liangyu ZouDepartment of Neurology, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology), Second Clinical College, Jinan University, Shenzhen, China.
Jinan University · CNFirst Affiliated Hospital of Jinan University · CNLonggang Central Hospital · CNShenzhen Center for Disease Control and Prevention · CNSixth Affiliated Hospital of Kunming Medical University · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseamyloid-1-42channelrhodopsin-2memoryneuro-inflammationneuroprotectionnovel object recognition

Identifiers

PMID33162881
PMCPMC7584457
OpenAlexW3091878622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.